GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 372 filers reported holding GLOBUS MED INC in Q1 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,929,153 | -73.5% | 119,419 | -68.3% | 0.00% | -80.0% |
| Q2 2023 | $22,394,899 | -68.0% | 376,132 | -69.5% | 0.01% | -66.7% |
| Q1 2023 | $69,886,113 | +344.1% | 1,233,865 | +482.4% | 0.02% | +400.0% |
| Q4 2022 | $15,735,957 | +42.7% | 211,875 | +14.4% | 0.00% | +50.0% |
| Q3 2022 | $11,030,000 | +275.8% | 185,173 | +254.1% | 0.00% | – |
| Q2 2022 | $2,935,000 | -70.6% | 52,291 | -61.4% | 0.00% | -100.0% |
| Q1 2022 | $9,995,000 | +24.9% | 135,478 | +22.2% | 0.00% | 0.0% |
| Q4 2021 | $8,002,000 | +93.4% | 110,831 | +105.2% | 0.00% | +100.0% |
| Q3 2021 | $4,138,000 | -43.1% | 54,004 | -42.4% | 0.00% | 0.0% |
| Q2 2021 | $7,273,000 | -2.3% | 93,800 | -22.3% | 0.00% | -50.0% |
| Q1 2021 | $7,448,000 | -50.6% | 120,775 | -47.8% | 0.00% | -33.3% |
| Q4 2020 | $15,088,000 | +129.6% | 231,351 | +74.3% | 0.00% | +50.0% |
| Q3 2020 | $6,571,000 | -40.1% | 132,721 | -42.2% | 0.00% | -50.0% |
| Q2 2020 | $10,963,000 | +15.7% | 229,796 | +3.2% | 0.00% | 0.0% |
| Q1 2020 | $9,473,000 | -40.3% | 222,742 | -17.3% | 0.00% | -42.9% |
| Q4 2019 | $15,866,000 | +608.0% | 269,468 | +514.4% | 0.01% | – |
| Q3 2019 | $2,241,000 | -28.3% | 43,858 | -40.7% | 0.00% | -100.0% |
| Q2 2019 | $3,127,000 | -63.5% | 73,916 | -57.4% | 0.00% | -75.0% |
| Q1 2019 | $8,564,000 | +500.6% | 173,342 | +426.4% | 0.00% | – |
| Q4 2018 | $1,426,000 | -45.9% | 32,930 | -29.0% | 0.00% | -100.0% |
| Q3 2018 | $2,634,000 | -54.3% | 46,400 | -59.4% | 0.00% | -50.0% |
| Q2 2018 | $5,763,000 | +88.7% | 114,198 | +86.3% | 0.00% | +100.0% |
| Q1 2018 | $3,054,000 | +360.6% | 61,305 | +280.4% | 0.00% | – |
| Q4 2017 | $663,000 | +0.2% | 16,117 | -27.6% | 0.00% | – |
| Q3 2017 | $662,000 | -47.5% | 22,273 | -41.4% | 0.00% | -100.0% |
| Q2 2017 | $1,260,000 | -89.7% | 37,996 | -90.8% | 0.00% | -90.9% |
| Q1 2017 | $12,227,000 | +2919.0% | 412,809 | +2430.6% | 0.01% | – |
| Q4 2016 | $405,000 | -95.9% | 16,313 | -96.3% | 0.00% | -100.0% |
| Q3 2016 | $9,971,000 | +136.5% | 441,793 | +149.7% | 0.01% | +100.0% |
| Q2 2016 | $4,216,000 | -19.8% | 176,921 | -20.1% | 0.01% | -28.6% |
| Q1 2016 | $5,257,000 | +390.4% | 221,329 | +474.7% | 0.01% | +600.0% |
| Q4 2015 | $1,072,000 | -79.1% | 38,511 | -84.5% | 0.00% | -80.0% |
| Q3 2015 | $5,141,000 | +82.5% | 248,815 | +126.7% | 0.01% | +150.0% |
| Q2 2015 | $2,817,000 | +319.2% | 109,750 | +312.4% | 0.00% | +100.0% |
| Q1 2015 | $672,000 | -70.0% | 26,613 | -71.7% | 0.00% | -50.0% |
| Q4 2014 | $2,238,000 | +48.9% | 94,138 | +23.2% | 0.00% | 0.0% |
| Q3 2014 | $1,503,000 | -48.3% | 76,383 | -37.2% | 0.00% | -33.3% |
| Q2 2014 | $2,909,000 | +175.2% | 121,609 | +206.0% | 0.00% | +200.0% |
| Q1 2014 | $1,057,000 | +31.5% | 39,739 | -0.2% | 0.00% | 0.0% |
| Q4 2013 | $804,000 | +222.9% | 39,806 | +179.5% | 0.00% | – |
| Q3 2013 | $249,000 | – | 14,244 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 373,254 | $26,949,000 | 17.58% |
| Next Capital Management LLC | 111,098 | $8,021,000 | 5.42% |
| Sterling Investment Advisors, Ltd. | 188,123 | $13,582,000 | 3.82% |
| Integral Health Asset Management, LLC | 180,000 | $12,996,000 | 3.60% |
| Pembroke Management, LTD | 602,447 | $43,497,000 | 3.19% |
| Godshalk Welsh Capital Management, Inc. | 73,435 | $5,302,000 | 3.02% |
| XXEC, Inc. | 51,925 | $3,420,000 | 2.92% |
| Sivik Global Healthcare LLC | 75,000 | $5,415,000 | 2.32% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 654,100 | $47,226,000 | 2.11% |
| Van Berkom & Associates Inc. | 929,856 | $67,136,000 | 1.98% |